Search Results - "Boks, M.P.M"

Cannabidiol as a potential treatment for psychosis by Schubart, C.D, Sommer, I.E.C, Fusar-Poli, P, de Witte, L, Kahn, R.S, Boks, M.P.M

“…Abstract Although cannabis use is associated with an increased risk of developing psychosis, the cannabis constituent cannabidiol (CBD) may have antipsychotic…”
Get full text

Antipsychotic use is associated with a blunted cortisol stress response: A study in euthymic bipolar disorder patients and their unaffected siblings by Houtepen, L.C, Boks, M.P.M, Kahn, R.S, Joëls, M, Vinkers, C.H

“…Abstract There is ample evidence that the acute stress response is altered in schizophrenia and bipolar disorder. However, it is not clear whether such changes…”
Get full text

Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences by van Gastel, W.A, Vreeker, A, Schubart, C.D, MacCabe, J.H, Kahn, R.S, Boks, M.P.M

“…Abstract Objective To prospectively assess the relationship between cannabis use and psychotic experiences over time. Method In a longitudinal design, young…”
Get full text

P.2.d.041 Determinants of acute stress reactivity in euthymic bipolar disorder patients and their unaffected siblings by Houtepen, L, Boks, M.P.M, Kahn, R.S, Joëls, M, Vinkers, C.H

Get full text

P.1.a.024 Deoxyribonucleic acid methylation marks of psychotropic drug use in bipolar disorder patients; an explorative pilot study by Houtepen, L, Van Bergen, A, Ophoff, R.A, Kahn, R.S, Vinkers, C.H, Boks, M.P.M

Get full text

Acute stress effects on GABA and glutamate levels in the prefrontal cortex: A 7T 1H magnetic resonance spectroscopy study by Houtepen, L.C., Schür, R.R., Wijnen, J.P., Boer, V.O., Boks, M.P.M., Kahn, R.S., Joëls, M., Klomp, D.W., Vinkers, C.H.

“…There is ample evidence that the inhibitory GABA and the excitatory glutamate system are essential for an adequate response to stress. Both GABAergic and…”
Get full text

P.3.025 The acute stress response in euthymic bipolar disorder patients and their siblings by Houtepen, L, Boks, M.P.M, Kahn, R.S, Joëls, M, Vinkers, C.H

Get full text

Longitudinal methylation changes in the glucocorticoid receptor 1F region and psychopathology after deployment by Schür, R, Boks, M.P.M, Geuze, E, Daskalakis, N.P, De Nijs, L, Rutten, B.P.F, Joëls, M, Kahn, R.S, Vermetten, E, Vinkers, C.H

Get full text

EPA-0848 – Stress reactivity in euthymic bipolar patietns and their unaffected siblings by Vinkers, C, Houtepen, L, Kahn, R.S, Joels, M, Boks, M.P.M

“…Background Bipolar disorder is characterized by depressive and manic mood episodes. Despite an overall high heritability, environmental factors play a critical…”
Get full text

Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia by Boks, M.P.M, Rietkerk, T, van de Beek, M.H, Sommer, I.E, de Koning, T.J, Kahn, R.S

“…Abstract We review the role of two susceptibility genes; G72 and DAAO in glutamate neurotransmission and the aetiology of schizophrenia. The gene product of…”
Get full text

O-58 - Suicide and suicide attempts during use of antidepressants: high risk at young age? by Termorshuizen, F, Smeets, H.M, Engelhard, I.M, Boks, M.P.M

“…Introduction Since 2003, the Food and Drug Agency (FDA) issued a number of advisory warnings regarding the association between use of antidepressants (ADs) and…”
Get full text

The genetics of symptom dimensions of schizophrenia: Review and meta-analysis by Rietkerk, T, Boks, M.P.M, Sommer, I.E, Liddle, P.F, Ophoff, R.A, Kahn, R.S

“…Abstract Background The use of symptom dimensions of schizophrenia as quantitative phenotypes has been proposed as a mean to reduce the heterogeneity of…”
Get full text

The involvement of GSK3β in bipolar disorder: Integrating evidence from multiple types of genetic studies by Luykx, J.J, Boks, M.P.M, Terwindt, A.P.R, Bakker, S, Kahn, R.S, Ophoff, R.A

“…Abstract We aimed to get a comprehensive insight into the genetic evidence supporting the role of GSK3β in bipolar disorder (BD). Using broad searches in…”
Get full text

Comparing language lateralization in psychotic mania and psychotic depression to schizophrenia; A functional MRI study by Sommer, I.E.C, vd Veer, A.J, Wijkstra, J, Boks, M.P.M, Kahn, R.S

Get full text

96 – Data-driven diagnosis of “psychosis without mood symptoms” shows higher loadings of schizophrenia risk factors by Leask, S.J, Boks, M.P.M, Vermunt, J.K, Done, D.J, Crow, T.J

Get full text

P.4.16 Cannabis use and subclinical psychotic symptoms: is the public mental health at risk? by Schubart, C.D, Boks, M.P.M, Sommer, I.E.C, Breetvelt, E.J, Beetz, S.L, van Gastel, W, Ophoff, R.A, Kahn, R.S

Get full text

Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings by LUYKX, J. J, LABAN, K. G, VAN DEN HEUVEL, M. P, BOKS, M. P. M, MANDL, R. C. W, KAHN, R. S, BAKKER, S. C

Get full text

P.1.a.010 - Longitudinal methylation changes in the glucocorticoid receptor 1F region and psychopathology after deployment by Schür, R., Boks, M.P.M., Geuze, E., Daskalakis, N.P., De Nijs, L., Rutten, B.P.F., Joëls, M., Kahn, R.S., Vermetten, E., Vinkers, C.H.

Get full text

Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma by Luykx, J J, Bakker, S C, Visser, W F, Verhoeven-Duif, N, Buizer-Voskamp, J E, den Heijer, J M, Boks, M P M, Sul, J H, Eskin, E, Ori, A P, Cantor, R M, Vorstman, J, Strengman, E, DeYoung, J, Kappen, T H, Pariama, E, van Dongen, E P A, Borgdorff, P, Bruins, P, de Koning, T J, Kahn, R S, Ophoff, R A

“…The N -methyl- d -aspartate receptor (NMDAR) coagonists glycine, d -serine and l -proline play crucial roles in NMDAR-dependent neurotransmission and are…”
Get full text

Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways by Rietkerk, T, Boks, M P M, Sommer, I E C, de Jong, S, Kahn, R S, Ophoff, R A

Get full text